Exigen Group take control of 50-year-old firm amid sector headwinds and winding-up petition
Motherwell-based biotech enters administration after NASDAQ delisting and liquidity crisis
Court appointment follows FCA move to safeguard customer funds after suspected misappropriation
Firm vicariously liable after partner failed to question source of misappropriated funds used in London property deals
Court restrains JSC from pursuing €850 million Russian actions, finding deliberate attempts to relitigate void pledge agreements
Key insights from our latest panel discussion on the restructuring of DSTBTD Limited